Clinical Trial Update: Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

Phase I trial update for CT0180 cells in advanced hepatocellular carcinoma; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• CT0180 Cells (CT0180 cells)

Snippet

Sponsor: Zhejiang University | Conditions: Advanced Hepatocellular Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING